- 5 Résultats
prix le plus bas: € 83,10, prix le plus élevé: € 237,21, prix moyen: € 156,86
1
New Drug Development: A Regulatory Overview (New Drug Development ( Mathieu)) - Mark Mathieu
Commander
sur amazon.com
$ 97,00
(environ € 83,10)
CommanderLien sponsorisé
Mark Mathieu:

New Drug Development: A Regulatory Overview (New Drug Development ( Mathieu)) - edition reliée, livre de poche

2008, ISBN: 1882615859

[SR: 918613], Hardcover, [EAN: 9781882615858], Parexel Intl Corp, Parexel Intl Corp, Book, [PU: Parexel Intl Corp], Parexel Intl Corp, Go inside the drug development and FDA regulatory pr… Plus…

  - Gebraucht. Frais d'envoiUsually ships in 1-2 business days., Livraison non-comprise Ponnu Padiyara
2
New Drug Development: A Regulatory Overview (New Drug Development ( Mathieu)) - Mark Mathieu
Commander
sur amazon.com
$ 145,00
(environ € 124,23)
CommanderLien sponsorisé

Mark Mathieu:

New Drug Development: A Regulatory Overview (New Drug Development ( Mathieu)) - edition reliée, livre de poche

2008, ISBN: 1882615859

[SR: 918613], Hardcover, [EAN: 9781882615858], Parexel Intl Corp, Parexel Intl Corp, Book, [PU: Parexel Intl Corp], Parexel Intl Corp, Go inside the drug development and FDA regulatory pr… Plus…

  - Neuware. Frais d'envoiUsually ships in 24 hours., Livraison non-comprise Amazon.com
3
New Drug Development: A Regulatory Overview - Mathieu, Mark P.
Commander
sur amazon.de
€ 237,21
Envoi: € 3,001
CommanderLien sponsorisé
Mathieu, Mark P.:
New Drug Development: A Regulatory Overview - edition reliée, livre de poche

2008

ISBN: 9781882615858

Mitwirkende: Milne, Christopher-Paul, Parexel International Corporation, Gebundene Ausgabe, Auflage: Revised, 362 Seiten, Publiziert: 2008-01-01T00:00:01Z, Produktgruppe: Buch, 1.22 kg, P… Plus…

Frais d'envoiReal shipping costs can differ from the ones shown here. (EUR 3.00)
4
New Drug Development: A Regulatory Overview (New Drug Development ( Mathieu)) - Mark Mathieu
Commander
sur AbeBooks.co.uk
£ 135,48
(environ € 155,07)
Envoi: € 16,441
CommanderLien sponsorisé
Mark Mathieu:
New Drug Development: A Regulatory Overview (New Drug Development ( Mathieu)) - edition reliée, livre de poche

2008, ISBN: 1882615859

[EAN: 9781882615858], New book, [SC: 16.44], [PU: Parexel Intl Corp], Brand New!, Books

NEW BOOK. Frais d'envoi EUR 16.44 Save With Sam, North Miami, FL, U.S.A. [65537386] [Rating: 5 (of 5)]
5
New Drug Development - Mark Mathieu (author), Christopher-Paul Milne (contributions)
Commander
sur Blackwells.co.uk
£ 161,35
(environ € 184,68)
Envoi: € 0,001
CommanderLien sponsorisé
Mark Mathieu (author), Christopher-Paul Milne (contributions):
New Drug Development - edition reliée, livre de poche

ISBN: 9781882615858

hardback

in stock. Frais d'envoiUnknown. (EUR 0.00) Blackwells.co.uk

1Comme certaines plateformes ne transmettent pas les conditions d'expédition et que celles-ci peuvent dépendre du pays de livraison, du prix d'achat, du poids et de la taille de l'article, d'une éventuelle adhésion de la plateforme, d'une livraison directe par la plateforme ou via un prestataire tiers (Marketplace), etc. il est possible que les frais de livraison indiqués par eurolivre ne correspondent pas à ceux de la plateforme qui propose l'article.

Données bibliographiques du meilleur livre correspondant

Détails sur le livre
New Drug Development: A Regulatory Overview

Go inside the drug development and FDA regulatory process with today's most authoritative and popular reference on the topic. In its all-new 2008 edition, New Drug Development: A Regulatory Overview addresses the most cutting-edge developments redefining how new drugs are developed and regulated today, including:

* How the FDA Amendments Act of 2007 will affect everything from drug reviews to postmarketing requirements.

* How the CDER's efforts to integrate a culture of drug safety has affected the center's structure and its new drug review and approval processes.

* How CDER's much-anticipated January 2008 transition to the eCTD as the only valid esubmission format will affect the FDA's drug submission and review process.

* How the FDA and industry are already integrating pharmacogenomics, computer simulation, and other emerging technologies to inform key decisions.

* Which drug development strategies are fulfilling their promise and offering optimal returns for industry, given the explosion of accelerated development/approval programs and pilot programs to speed the drug development and review process.


Find out why New Drug Development is pharma/biotech's go-to resource for regulatory, clinical, project management, training, and other drug development disciplines navigating the FDA's drug development approval processes.

Informations détaillées sur le livre - New Drug Development: A Regulatory Overview


EAN (ISBN-13): 9781882615858
ISBN (ISBN-10): 1882615859
Version reliée
Date de parution: 2008
Editeur: Parexel International Corporation
362 Pages
Poids: 1,260 kg
Langue: eng/Englisch

Livre dans la base de données depuis 2009-02-24T14:23:34+01:00 (Zurich)
Page de détail modifiée en dernier sur 2023-11-01T07:39:46+01:00 (Zurich)
ISBN/EAN: 9781882615858

ISBN - Autres types d'écriture:
1-882615-85-9, 978-1-882615-85-8
Autres types d'écriture et termes associés:
Auteur du livre: mark mathieu, christopher milne
Titre du livre: mathieu, new drug development


Autres livres qui pourraient ressembler au livre recherché:

Dernier livre similaire:
9780931283062 New drug development: A regulatory overview (Mark P. (editor) Mathieu)


< pour archiver...